IPO Monitor
Subscribe Login Login About Us Contact Us Help
Recent Filings - Secondary Offerings
Date Company Location Amount
2018-03-19 Dicerna Pharmaceuticals, Inc. Watertown, MA $333.6 mil.
 A biopharmaceutical company
2018-03-19 ObsEva SA Geneva, SWITZERLAND $50.0 mil.
 A clinical-stage biopharmaceutical company
2018-03-19 Easterly Government Properties, Inc. Washington, DC $100.0 mil.
 A real estate investment trust
2018-03-19 Egalet Corp. Malvern, PA $16.1 mil.
 A specialty pharmaceutical company
2018-03-19 Proteostasis Therapeutics, Inc. Cambridge, MA N/A
 An innovative biopharmaceutical company
2018-03-16 Organovo Holdings, Inc. San Diego, CA $50.0 mil.
 Develops and commercializes functional human tissues
2018-03-16 WillScot Corp Baltimore, MD $1,000.0 mil.
 A market leader in the North America specialty rental services industry.
2018-03-16 Nabriva Therapeutics plc Dublin, IRELAND $225.0 mil.
 A clinical stage biopharmaceutical company
2018-03-16 NantHealth, Inc. Culver City, CA $200.0 mil.
 A leading next-generation, evidence-based, personalized healthcare company
2018-03-16 Heat Biologics, Inc. Chapel Hill, NC $1.30 mil.
 A clinical-stage biopharmaceutical company
2018-03-15 Histogenics Corporation Waltham, MA $10.0 mil.
 A regenerative medicine company
2018-03-15 The ExOne Company North Huntingdon, PA $125.0 mil.
 Provides three-dimensional (3D) printing machines and printed products to industrial customers.
2018-03-15 Pfenex Inc. San Diego, CA $20.0 mil.
 A clinical-stage biotechnology
2018-03-15 Lightbridge Corp. McLean, VA $75.0 mil.
 A provider of nuclear energy consulting and strategic advisory services.
2018-03-14 Unit Corporation Tulsa, OK $81.0 mil.
 An oil and natural gas contract drilling company.
2018-03-14 Apollo Commercial Real Estate Finance Inc. New York, NY $290.0 mil.
 A newly organized commercial real estate finance company.
2018-03-14 La Jolla Pharmaceutical Co. San Diego, CA $100.3 mil.
 Develops highly specific therapeutic products for the treatment of certain life-threatening antibody-mediated diseases.
2018-03-14 Invuity, Inc. San Francisco, CA $21.7 mil.
 A commercial-stage medical technology company
2018-03-14 Intellipharmaceutics International Inc. Toronto, Ontario, CANADA $3.50 mil.
 A pharmaceutical company.
2018-03-14 Vanda Pharmaceuticals Inc. Rockville, MD $93.5 mil.
 Is a biopharmaceutical company.
More >>

[ Contact Us | About Us | Site Map ]

Copyright (c) 1998-2018 IPO Monitor. All rights reserved